Related Experiment Videos

[Role of Fas system in apoptosis induced by hepatitis C virus infection]

E Mita¹, N Hayashi, T Kamada

¹First Department of Medicine, Osaka University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|September 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1.

Journal of viral hepatitis·2014

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.

Journal of viral hepatitis·2014

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

Journal of viral hepatitis·2009

Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.

Journal of viral hepatitis·2009

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.

Journal of viral hepatitis·2009

Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic response.

Journal of gastroenterology and hepatology·2001

See all related articles